• OSI Docketing

Only documents signed by the correct party, person, representative or attorney with a completed certificate of service attached will be accepted for electronic filing. Scanned or facsimile signatures or electronic signatures conforming to federal and state court requirements will be accepted with the understanding that if there is any dispute regarding a signature, OSI reserves the right to require that original signatures be provided to verify the electronic or facsimile signature.

All filings must be received between the hours of 8:00 a.m. and 4:00 p.m. Monday through Friday except on state holidays. Any filings received after 4:00 p.m. will be filed to the docket the next business day.

Formal Hearing Request

To request a formal hearing before the Superintendent, please complete the Request for Informal Hearing Form provided below. Instructions for submitting the form are included at the bottom of the form.

Informal Hearing Request

To request an informal hearing before the Superintendent, please complete the Request for Informal Hearing Form provided below. Instructions for submitting the form are included at the bottom of the form.

Select “Records and Docketing” to contact Records and Docketing Bureau.

Recent News

Get the latest information about rule changes, legislation, industry information and consumer news.

Read All OSI News

MEDICAL MALPRACTICE PREMIUM REDUCTION

AMENDED BULLETIN 2026-010: The New Mexico State Legislature appropriated $5 million to the New Mexico Office of Superintendent of Insurance (OSI) to address medical malpractice insurance costs for individual providers. The appropriation was part of a supplemental appropriation package passed in 2025. This one-time appropriation directs OSI to provide a premium subsidy for private medical malpractice insurance policies. […]

Read More

NOTICE OF PRESCRIPTION DRUG PRICE TRANSPARENCY ANNUAL MEETING

The Office of the Superintendent of Insurance will hold its annual public meeting to present and discuss the findings and recommendations contained in the 2025 Prescription Drug Price Transparency legislative report. The purpose of this meeting is to inform the public of the report’s contents and to provide an opportunity for public comments and questions. […]

Read More